Human IgG antibody Laboratories manufactures the sars test panel reagents distributed by Genprice. The Sars Test Panel reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Sars products are available in stock. Specificity: Sars Category: Test Group: Panel
CMV (Cytomegalovirus Antibody IgG) ELISA test |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of CMV (Cytomegalovirus Antibody IgG) |
ACA (Anticardiolipin Antibody IgG) ELISA test |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of ACA (Anticardiolipin Antibody IgG) |
TOX (Toxoplasma Antibody IgG) ELISA test |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of TOX (Toxoplasma Antibody IgG) |
ANA (Antinuclear Antibody IgG) ELISA test |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of ANA (Antinuclear Antibody IgG) |
HPV (Human Papilloma Virus Antibody IgG) ELISA test |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of HPV (Human Papilloma Virus Antibody IgG) |
HDV-IgG hepatitis D IgG ELISA test |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of HDV-IgG hepatitis D IgG |
Panel information
SARS-CoV-2 Variants Neutralizing Antibody 6-plex Panel (Flow Cytometry Multiplex Bead Assay) |
FCM-N04R |
ACROBIOSYSTEMS |
96tests |
EUR 1187.7 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a multiplex serological test for assessing antibody responses to mutant strains is in urgent need. |
SARS-CoV-2 Omicron Sublineages Total IgG 6-plex Panel (Flow Cytometry Multiplex Bead Assay) |
FCM-B18R |
ACROBIOSYSTEMS |
96tests |
EUR 1187.7 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
SARS-CoV-2 Variants Total IgG 6-plex Panel (Flow Cytometry Multiplex Bead Assay, Non-premixed) |
FCM-B08R |
ACROBIOSYSTEMS |
96tests |
EUR 1187.7 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a multiplex serological test for assessing antibody responses to mutant strains is in urgent need. |
Avacta AffiDX SARS-CoV-2 Antigen Lateral Flow Test |
BSV-COV-11711125 |
BioServUK |
25 tests |
Ask for price |
Description: Avacta AffiDX SARS-CoV-2 Antigen Lateral Flow Test |
Mouse SARS-CoV-2 Omicron Subvariants Total IgG 5-plex Panel (Flow Cytometry Multiplex Bead Assay) |
FCM-B07R |
ACROBIOSYSTEMS |
96tests |
EUR 1187.7 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide. Omicron is a variant of SARS-CoV-2 first detected in November 2021 and is causing the ongoing COVID-19 pandemic. The Omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. Its recent descendants BA.2.12.1 and BA.4/5 have surged dramatically to become dominant in the United States and South Africa, respectively. BA.2.12.1 and BA.4/BA.5 exhibit comparable ACE2-binding affinities to BA.2. Importantly, BA.2.12.1 and BA.4/BA.5 display stronger neutralization evasion than BA.2 against the plasma from 3-dose vaccination and, most strikingly, from post-vaccination BA.1 infections. |
Human SARS-CoV-2 Omicron Subvariants Total IgG 6-plex Panel (Flow Cytometry Multiplex Bead Assay) |
FCM-B09R |
ACROBIOSYSTEMS |
96tests |
EUR 1187.7 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide. Omicron is a variant of SARS-CoV-2 first detected in November 2021 and is causing the ongoing COVID-19 pandemic. The Omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. Its recent descendants BA.2.12.1 and BA.4/5 have surged dramatically to become dominant in the United States and South Africa, respectively. BA.2.12.1 and BA.4/BA.5 exhibit comparable ACE2-binding affinities to BA.2. Importantly, BA.2.12.1 and BA.4/BA.5 display stronger neutralization evasion than BA.2 against the plasma from 3-dose vaccination and, most strikingly, from post-vaccination BA.1 infections.Omicron BA.2.75 (a sub-variant of the BA.2 lineage) appears more transmissible than BA.5 in India and Nepal. Moreover, the World Health Organization (WHO) has lately classified BA.2.75 as a variant of concern lineages under monitoring (VOC-LUM). |
Mouse SARS-CoV-2 Omicron Sublineages Total IgG 6-plex Panel (Flow Cytometry Multiplex Bead Assay) |
FCM-B19R |
ACROBIOSYSTEMS |
96tests |
EUR 1187.7 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide.As the virus spreads globally, the continuous emergence of new mutant strains escalated the challenge on humans.To facilitate the mutant-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the mutants is in urgent need. |
SARS-CoV-2 Omicron Subvariants Neutralizing Antibody 5-plex Panel (Flow Cytometry Multiplex Bead Assay) |
FCM-N06R |
ACROBIOSYSTEMS |
96tests |
EUR 1187.7 |
|
Description: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has caused a devastating pandemic worldwide. Omicron is a variant of SARS-CoV-2 first detected in November 2021 and is causing the ongoing COVID-19 pandemic. The Omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. Its recent descendants BA.2.12.1 and BA.4/5 have surged dramatically to become dominant in the United States and South Africa, respectively. BA.2.12.1 and BA.4/BA.5 exhibit comparable ACE2-binding affinities to BA.2. Importantly, BA.2.12.1 and BA.4/BA.5 display stronger neutralization evasion than BA.2 against the plasma from 3-dose vaccination and, most strikingly, from post-vaccination BA.1 infections. |
Lysis Buffer for SARS-CoV-2 Antigen Test Development |
LY-14 |
ACROBIOSYSTEMS |
10ml |
EUR 973.7 |
|
Description: N/A |
2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) |
GEN-402-25tests |
All test |
25 tests |
EUR 292.8 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) |
IOV87952 |
INVBIO |
20T/kit |
EUR 46.8 |
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications. |
Rat Testis Developmental Total Protein Panel, any 6 stages |
RT-401-006D |
Zyagen |
6x0.1mg |
EUR 1289 |